Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors.
Cancer Chemother Pharmacol. 2011 Oct;68(4):959-70. doi: 10.1007/s00280-011-1565-4. Epub 2011 Feb 9.
Cancer Chemother Pharmacol. 2011.
PMID: 21305290
Clinical Trial.
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.
Traynor AM, Gordon MS, Alberti D, Mendelson DS, Munsey MS, Wilding G, Gammans RE, Read WL.
Traynor AM, et al. Among authors: munsey ms.
Invest New Drugs. 2010 Aug;28(4):509-15. doi: 10.1007/s10637-009-9264-2. Epub 2009 May 13.
Invest New Drugs. 2010.
PMID: 19434370
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite